ARSENIC TRIOXIDE FOR INJECTION DIN 02541971
Health Canada record
| Active ingredient(s) | ARSENIC TRIOXIDE 2 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01XX27 ARSENIC TRIOXIDE |
| Original market date | |
| Current status date | 06-Oct-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eugia Pharma Inc. — licence 3-002768, currently licensed, last inspection rating C (2026-02-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ARSENIC TRIOXIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02554364 | ARSENIC TRIOXIDE FOR INJECTION | MARCAN PHARMACEUTICALS INC | Solution | ARSENIC TRIOXIDE 1 MG | Marketed |
| 02540517 | ARSENIC TRIOXIDE FOR INJECTION | AURO PHARMA INC | Solution | ARSENIC TRIOXIDE 2 MG | Approved |
| 02513420 | ARSENIC TRIOXIDE FOR INJECTION | SANDOZ CANADA INCORPORATED | Solution | ARSENIC TRIOXIDE 10 MG | Marketed |
| 02492768 | ARSENIC TRIOXIDE FOR INJECTION | STERIMAX INC | Solution | ARSENIC TRIOXIDE 1 MG | Marketed |
| 02487357 | ARSENIC TRIOXIDE SOLUTION FOR INJECTION | PHEBRA PTY LTD | Solution | ARSENIC TRIOXIDE 10 MG | Marketed |
| 00718777 | ARSENICUM ALBUM 3CH-30CH GLOBULES | BOIRON LABORATOIRES | Tablet | ARSENIC TRIOXIDE 3 CH | Cancelled Post Market |
| 00226246 | HERBAMINE | DR RECKEWEG AND CO | Liquid | ARSENIC TRIOXIDE 8 X; BELLADONNA 30 X; BRYONIA 12 X; CHARCOAL ACTIVATED 12 X; PITUITARY POSTERIOR 12 X; SODIUM SULFATE 30 X; WHITE HELLEBORE ROOT 30 X; ERIODICTYON 12 X | Cancelled Post Market |
| 02484366 | TEVA-ARSENIC TRIOXIDE FOR INJECTION | TEVA CANADA LIMITED | Solution | ARSENIC TRIOXIDE 12 MG | Cancelled Pre Market |
| 02484358 | TEVA-ARSENIC TRIOXIDE FOR INJECTION | TEVA CANADA LIMITED | Solution | ARSENIC TRIOXIDE 10 MG | Cancelled Pre Market |
| 02480387 | TRISENOX | TEVA CANADA LIMITED | Solution | ARSENIC TRIOXIDE 12 MG | Cancelled Post Market |
| 02407833 | TRISENOX | TEVA CANADA LIMITED | Solution | ARSENIC TRIOXIDE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 31796 | 2023-10-06 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement Between Two Manufacturers |
International API supply for ARSENIC TRIOXIDE
5 active FDA Drug Master Files.
Request a quote for ARSENIC TRIOXIDE FOR INJECTION